Cargando…

Inhibitory effects of osteoprotegerin on osteoclast formation and function under serum-free conditions

The purpose of this study was to determine whether osteoprotegerin (OPG) could affect osteoclat differentiation and activation under serum-free conditions. Both duck embryo bone marrow cells and RAW264.7 cells were incubated with macrophage colony stimulatory factor (M-CSF) and receptor activator fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Ying-Xiao, Gu, Jian-Hong, Zhang, Yi-Ran, Tong, Xi-Shuai, Zhao, Hong-Yan, Yuan, Yan, Liu, Xue-Zhong, Bian, Jian-Chun, Liu, Zong-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Veterinary Science 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885733/ https://www.ncbi.nlm.nih.gov/pubmed/23820214 http://dx.doi.org/10.4142/jvs.2013.14.4.405

Ejemplares similares

The Function of Naringin in Inducing Secretion of Osteoprotegerin and Inhibiting Formation of Osteoclasts
por: Xu, Tong, et al.
Publicado: (2016)

Involvement of the Ca(2+) signaling pathway in osteoprotegerin inhibition of osteoclast differentiation and maturation
por: Fu, Yingxiao, et al.
Publicado: (2015)

Osteoprotegerin Induces Apoptosis of Osteoclasts and Osteoclast Precursor Cells via the Fas/Fas Ligand Pathway
por: Liu, Wei, et al.
Publicado: (2015)

Regulation of matrix metalloproteinase-9 protein expression by 1α,25-(OH)(2)D(3) during osteoclast differentiation
por: Gu, Jian-Hong, et al.
Publicado: (2014)

The Mechanism of Osteoprotegerin-Induced Osteoclast Pyroptosis In Vitro
por: Zhu, Jiaqiao, et al.
Publicado: (2023)

Chondrocytes-Specific Expression of Osteoprotegerin Modulates Osteoclast Formation in Metaphyseal Bone
por: Wang, Baoli, et al.
Publicado: (2015)

Unfractionated Heparin Promotes Osteoclast Formation in Vitro by Inhibiting Osteoprotegerin Activity
por: Li, Binghan, et al.
Publicado: (2016)

Suppression of AMP‐activated protein kinase reverses osteoprotegerin‐induced inhibition of osteoclast differentiation by reducing autophagy
por: Tong, Xishuai, et al.
Publicado: (2019)

The Ligand for Osteoprotegerin (OPGL) Directly Activates Mature Osteoclasts
por: Burgess, Teresa L., et al.
Publicado: (1999)

Soluble TRAIL does not impair the anti-osteoclastic activity of osteoprotegerin
por: Zauli, Giorgio, et al.
Publicado: (2008)

Osteoprotegerin reduces osteoclast resorption activity without affecting osteogenesis on nanoparticulate mineralized collagen scaffolds
por: Ren, Xiaoyan, et al.
Publicado: (2019)

Abstract: Osteoprotegerin-Mediated Osteoclast Inhibition Is Augmented on Nanoparticulate Mineralized Collagen Glycosaminoglycan Materials
por: Lee, Justine C., et al.
Publicado: (2018)

The Impact of Hyperbaric Oxygen Therapy on Serum C-Reactive Protein Levels, Osteoprotegerin Expression, and Osteoclast Numbers in Induced-Periodontitis Diabetic Rats
por: Mulawarmanti, Dian, et al.
Publicado: (2020)

Therapeutic targeting of osteoclasts by osteoprotegerin and bisphosphonates leads to a reduction of TNFalpha-mediated bone resorption
por: Redlich, K, et al.
Publicado: (2001)

Targeting syndecan-1 in breast cancer inhibits osteoclast functions through up-regulation of osteoprotegerin
por: Benad-Mehner, Peggy, et al.
Publicado: (2013)

The Simultaneous Inhibitory Effect of Niclosamide on RANKL-Induced Osteoclast Formation and Osteoblast Differentiation
por: Liu, Fei-Lan, et al.
Publicado: (2017)

Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts
por: Hou, Lele, et al.
Publicado: (2011)

Murine osteoclasts secrete serine protease HtrA1 capable of degrading osteoprotegerin in the bone microenvironment
por: Ochiai, Nagahiro, et al.
Publicado: (2019)

The Role of Galectin-3 in 1α,25(OH)(2)D(3)-Regulated Osteoclast Formation from White Leghorn Chickens In Vitro
por: Gu, Jianhong, et al.
Publicado: (2021)

Plasma osteoprotegerin predicts adverse cardiovascular events in stable coronary artery disease: the PEACE trial
por: Ma, Teng, et al.
Publicado: (2023)

Inhibitory Effect of Probenecid on Osteoclast Formation via JNK, ROS and COX-2
por: Cheng, Mi Hyun, et al.
Publicado: (2020)

Overexpression of c‐Fos reverses osteoprotegerin‐mediated suppression of osteoclastogenesis by increasing the Beclin1‐induced autophagy
por: Tong, Xishuai, et al.
Publicado: (2020)

Osteoprotegerin Reverses Osteoporosis by Inhibiting Endosteal Osteoclasts and Prevents Vascular Calcification by Blocking a Process Resembling Osteoclastogenesis
por: Min, Hosung, et al.
Publicado: (2000)

Osteoclasts secrete leukemia inhibitory factor to promote abnormal bone remodeling of subchondral bone in osteoarthritis
por: Zhao, Xin, et al.
Publicado: (2022)

Dickkopf-1 negatively regulates the expression of osteoprotegerin, a key osteoclastogenesis inhibitor, by sequestering Lrp6 in primary and metastatic lytic bone lesions
por: Wang, Jian-Hang, et al.
Publicado: (2016)

miR-145-5p Increases Osteoclast Numbers In Vitro and Aggravates Bone Erosion in Collagen-Induced Arthritis by Targeting Osteoprotegerin
por: Chen, Yaqing, et al.
Publicado: (2018)

Inhibitory Effects of Rhaponticin on Osteoclast Formation and Resorption by Targeting RANKL-Induced NFATc1 and ROS Activity
por: He, Jianbo, et al.
Publicado: (2021)

Potential mechanisms of osteoprotegerin-induced damage to osteoclast adhesion structures via P2X7R-mediated MAPK signaling
por: Ma, Yonggang, et al.
Publicado: (2022)

Serum amyloid A inhibits RANKL-induced osteoclast formation
por: Oh, Eunseo, et al.
Publicado: (2015)

Mesenchymal stem cells inhibit RANK-RANKL interactions between osteoclasts and Th17 cells via osteoprotegerin activity
por: Cho, Kyung-Ah, et al.
Publicado: (2017)

Dental pulp–derived stem cells inhibit osteoclast differentiation by secreting osteoprotegerin and deactivating AKT signalling in myeloid cells
por: Kanji, Suman, et al.
Publicado: (2021)

Inhibitory Effects of Gold and Silver Nanoparticles on the Differentiation into Osteoclasts In Vitro
por: Lee, Daye, et al.
Publicado: (2021)

Serum osteoprotegerin levels are related to height loss: The Tromsø Study
por: Jørgensen, Lone, et al.
Publicado: (2011)

Serum osteoprotegerin is associated with pulse pressure in kidney transplant recipients
por: Nemeth, Zsofia K., et al.
Publicado: (2015)

Relationship between serum osteoprotegerin and vascular calcifications in hemodialysis patients
por: El Baz, Tarek Z., et al.
Publicado: (2017)

Serum osteoprotegerin and renal function in the general population: the Tromsø Study
por: Vik, Anders, et al.
Publicado: (2017)

Serum Osteoprotegerin Levels and the Vascular Reactivity Index in Patients with Hypertension
por: Chen, Yen-Liang, et al.
Publicado: (2023)

Vitamin D Inhibition of TRPV5 Expression During Osteoclast Differentiation
por: Gu, Jianhong, et al.
Publicado: (2019)

Therapeutic implications of osteoprotegerin
por: Fili, Sofia, et al.
Publicado: (2009)

The role of osteoprotegerin in arthritis
por: Schett, Georg, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_f66vcmuovlf1aid8f0kfut94gr